Almuradova D.M., Ravshanova N.B. and Abdurakhimov A.I. 2026. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. International Journal of Medical Sciences And Clinical Research. 6, 03 (Mar. 2026), 82–86. DOI:https://doi.org/10.37547/ijmscr/Volume06Issue03-18.